Sirt1 Promotes a Thermogenic Gene Program in Bone Marrow Adipocytes: From Mice to (Wo)Men
暂无分享,去创建一个
R. Müller | O. Safran | G. Kuhn | R. Dresner-Pollak | L. Kandel | H. Artsi | I. Gurt | M. El-Haj | Gal Ben Shalom | E. Cohen-Kfir | E. Abramowitz | R. Dresner‐Pollak
[1] Jiandie D. Lin,et al. PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ. , 2018, Cell stem cell.
[2] P. Carmeliet,et al. Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin , 2018, Nature Communications.
[3] M. Kassem,et al. High‐Fat Diet–Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] M. McQueen,et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults , 2018, Nature Communications.
[5] D. Sinclair,et al. Sirtuin activators and inhibitors: Promises, achievements, and challenges. , 2018, Pharmacology & therapeutics.
[6] J. Pettitt,et al. The skeletal cell‐derived molecule sclerostin drives bone marrow adipogenesis , 2018, Journal of cellular physiology.
[7] L. Guarente,et al. SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis , 2017, PloS one.
[8] B. Lecka-Czernik,et al. Marrow Adipose Tissue: Skeletal Location, Sexual Dimorphism, and Response to Sex Steroid Deficiency , 2017, Front. Endocrinol..
[9] C. Rubin,et al. Exercise Decreases Marrow Adipose Tissue Through ß‐Oxidation in Obese Running Mice , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] A. Scialdone,et al. Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration , 2017, Cell stem cell.
[11] L. Guarente,et al. SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2 , 2017, PloS one.
[12] A. Xu,et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue , 2017, EMBO reports.
[13] R. Baron,et al. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. , 2017, Cell metabolism.
[14] C. Edwards,et al. Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone , 2016, Front. Endocrinol..
[15] S. Morrison,et al. Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow. , 2016, Cell stem cell.
[16] M. Tamura,et al. Sclerostin Enhances Adipocyte Differentiation in 3T3‐L1 Cells , 2016, Journal of cellular biochemistry.
[17] B. Hinz,et al. Faculty Opinions recommendation of The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. , 2016 .
[18] O. Safran,et al. Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture , 2016, Osteoporosis International.
[19] Bruce M. Spiegelman,et al. Brown and Beige Fat: Physiological Roles beyond Heat Generation. , 2015, Cell metabolism.
[20] Jeff E. Mold,et al. Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis. , 2015, Cell metabolism.
[21] O. MacDougald,et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues , 2015, Nature Communications.
[22] R. Dresner-Pollak,et al. The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells , 2015, PloS one.
[23] W. R. Thompson,et al. Exercise Regulation of Marrow Fat in the Setting of PPARγ Agonist Treatment in Female C57BL/6 Mice. , 2015, Endocrinology.
[24] J. Cho,et al. Creatine inhibits adipogenesis by downregulating insulin-induced activation of the phosphatidylinositol 3-kinase signaling pathway. , 2015, Stem cells and development.
[25] P. Bianco,et al. Skeletal stem cells , 2015, Development.
[26] K. Thai,et al. SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes , 2015, Diabetologia.
[27] R. Borojevic,et al. Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells , 2014, BMC Cell Biology.
[28] C. Che,et al. Calorie Restriction Prevents Metabolic Aging Caused by Abnormal SIRT1 Function in Adipose Tissues , 2014, Diabetes.
[29] S. Morrison,et al. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. , 2014, Cell stem cell.
[30] O. MacDougald,et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. , 2014, Cell metabolism.
[31] R. de Cabo,et al. Sirtuin1 (Sirt1) Promotes Cortical Bone Formation by Preventing β-Catenin Sequestration by FoxO Transcription Factors in Osteoblast Progenitors* , 2014, The Journal of Biological Chemistry.
[32] T. Bellido,et al. The Sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice. , 2014, Endocrinology.
[33] C. Rosen,et al. Annals of the New York Academy of Sciences What's the Matter with Mat? Marrow Adipose Tissue, Metabolism, and Skeletal Health , 2022 .
[34] D. Saini,et al. A withanolide coagulin-L inhibits adipogenesis modulating Wnt/β-catenin pathway and cell cycle in mitotic clonal expansion. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[35] M. Weyand,et al. Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism , 2013, Proceedings of the National Academy of Sciences.
[36] J. Nyman,et al. Silent information regulator (Sir)T1 inhibits NF‐κB signaling to maintain normal skeletal remodeling , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] O. MacDougald,et al. Marrow fat and bone--new perspectives. , 2013, The Journal of clinical endocrinology and metabolism.
[38] L. Guarente,et al. SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin , 2013, EMBO molecular medicine.
[39] Xu Cao,et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.
[40] D. Accili,et al. Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ , 2012, Cell.
[41] Yuanxiang Zhao,et al. Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell Development , 2012, PloS one.
[42] Y. Lu,et al. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. , 2012, Bone.
[43] Yulin Li,et al. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: A possible cause for reduced osteogenesis and increased adipogenesis in older individuals , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] D. Toiber,et al. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. , 2011, Endocrinology.
[45] M. Rivera,et al. The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. , 2011, Developmental cell.
[46] P. Kostenuik,et al. Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] J. Fenton,et al. Short-term re-feeding of previously energy-restricted C57BL/6 male mice restores body weight and body fat and attenuates the decline in natural killer cell function after primary influenza infection. , 2010, The Journal of nutrition.
[48] Y. Hayashi,et al. Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.
[49] F. Villarroya,et al. SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-γ Co-activator-1α (PGC-1α) Gene in Skeletal Muscle through the PGC-1α Autoregulatory Loop and Interaction with MyoD* , 2009, The Journal of Biological Chemistry.
[50] M. Bredella,et al. Increased bone marrow fat in anorexia nervosa. , 2009, The Journal of clinical endocrinology and metabolism.
[51] G. Daley,et al. Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment , 2009, Nature.
[52] Qing Chen,et al. Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] Andrew D. Steele,et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction , 2007, Aging cell.
[54] S. Mandrup,et al. Patients With High Bone Mass Phenotype Exhibit Enhanced Osteoblast Differentiation and Inhibition of Adipogenesis of Human Mesenchymal Stem Cells , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] Dudley Lamming,et al. Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.
[56] B. Spiegelman,et al. Transcriptional control of brown fat determination by PRDM16. , 2007, Cell metabolism.
[57] D. Klemm,et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. , 2006, The Journal of clinical investigation.
[58] L. Guarente,et al. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.
[59] C. Bäckesjö,et al. Activation of Sirt1 Decreases Adipocyte Formation During Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[60] P. Tesar,et al. Characterizing medullary and human mesenchymal stem cell‐derived adipocytes , 2006, Journal of cellular physiology.
[61] Jiandie D. Lin,et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. , 2006, Cell metabolism.
[62] O. MacDougald,et al. Wnt Signaling Inhibits Adipogenesis through β-Catenin-dependent and -independent Mechanisms* , 2005, Journal of Biological Chemistry.
[63] Wilhelm Haas,et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.
[64] L. Guarente,et al. Calorie Restriction— the SIR2 Connection , 2005, Cell.
[65] J. Cedarbaum. Survival , 2004 .
[66] Namjin Chung,et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ , 2004, Nature.
[67] F. Alt,et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[68] D. Langin,et al. Acquirement of Brown Fat Cell Features by Human White Adipocytes* , 2003, Journal of Biological Chemistry.
[69] L. R. Ferreira,et al. Evaluation of different staining procedures for the quantification of fibroblasts cultured in 96-well plates. , 1991, Analytical biochemistry.
[70] L. Guarente,et al. SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2 , 2017, PloS one.
[71] S. Hui,et al. Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. , 2012, American journal of stem cells.
[72] Mary L Bouxsein,et al. Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.